spacer
home > epc > summer 2002 > making the right choice in pharmaceutical outsourcing
PUBLICATIONS
European Pharmaceutical Contractor

Making the Right Choice in Pharmaceutical Outsourcing

Outsourcing of analysis within the pharmaceutical industry has steadily increased in recent years and this trend seems set to continue with estimated growth being as high as 9 per cent per annum.

Key reasons for outsourcing analysis include:

Little or no facilities in-house

Utilisation of internal competence on higher value return science, such
as better value for money from internal staff

In-house capacity problems due to increased testing in line with regulations

The problem of choosing the right outsourcing partner has been exacerbated by the growth in the number of contract service organisations (CSOs) on the market. Often these organisations appear to offer similar services and returns for the customer - thus making the partnering decision difficult.

This article will explore four key areas worthy of consideration when selecting your outsourcing laboratory.

Balancing Cost and Confidence

When faced with the prospect of outsourcing you must be convinced of the viability and robustness of your decision to hand over control of a project to a third party. As the project manager, you must be confident about getting value for money, quality and delivery from your outsourcing partner.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Brian Arnot, Business Development Executive at Tepnel Scientific Services

Brian Arnot is an experienced Analytical Chemist who has worked in the contract analytical services sector since 1984.

More recently, he has joined the business development team of Tepnel Scientific Services (formerly the Medicines Testing Laboratory), where he is responsible for the development of core business activities in both the UK and Europe.

spacer
Brian Arnot
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research

BioFortis

Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate big data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDAs Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the worlds largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement